Skip to search
Skip to main content
Skip to first result
Maxine Singer - Profiles in Science
Contact
About
Maxine Singer
The Maxine Singer Papers
Home
The Story
Biographical Overview
Nucleic Acids, the Genetic Code, and Transposable Genetic Elements: A Life in Research
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
The Science Administrator as Advocate
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
Search Constraints
Start Over
You searched for:
Subject
DNA, Recombinant
✖
Remove constraint Subject: DNA, Recombinant
1
-
66
of
66
Sort
by Title (Z-A)
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
100
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
×
Wallace Rowe speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
1 of 66
The Scientific Committee on Genetic Experimentation (COGENE)
2 of 66
Testimony of Maxine Singer before the California State Legislature
3 of 66
Testimony by David Baltimore for the Committee on Science and Technology
4 of 66
Susan Wright speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
5 of 66
Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
6 of 66
Speaker from the audience at the March 1977 National Academy of Sciences Forum on Recombinant DNA
7 of 66
Roy Hudson listening in at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
8 of 66
Roy Curtiss III speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
9 of 66
Robert Sinsheimer speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
10 of 66
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
11 of 66
Protestors and their banner at the March 1977 National Academy of Sciences Forum on Recombinant DNA
12 of 66
Potential Biohazards of Recombinant DNA Molecules [Letter to the Editor of Science]
13 of 66
Paul Berg speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
14 of 66
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
15 of 66
Ordinance No. 5010: Regulating the Use of Hazardous Biological Research in the City of Berkeley
16 of 66
Open Letter to the Asilomar Conference on Hazards of Recombinant DNA
17 of 66
Minutes of the Eleventh Meeting of the Executive Recombinant DNA Committee
18 of 66
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
19 of 66
Memorandum from Michael Adler [summarizing the first day of hearings of the Thornton House Subcommittee on Science, Research, and Technology]
20 of 66
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
21 of 66
Memorandum from Maxine Singer to Donald S. Fredrickson
22 of 66
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
23 of 66
Maxine Singer, Norton Zinder, Sydney Brenner, and Paul Berg at the 1975 Asilomar Conference
24 of 66
Maxine Singer speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
25 of 66
Letter from Wallace P. Rowe to Maxine Singer
26 of 66
Letter from U.S. Representative Paul G. Rogers to Maxine Singer
27 of 66
Letter from Stanley N. Cohen to Maxine Singer
28 of 66
Letter from Roy Curtiss III to Maxine Singer
29 of 66
Letter from Roy Curtiss III to Donald S. Fredrickson
30 of 66
Letter from Roy Curtiss III to Donald S. Fredrickson
31 of 66
Letter from Paul Berg to U.S. Senator Harrison Schmitt
32 of 66
Letter from Paul Berg to Robert L. Sinsheimer
33 of 66
Letter from Maxine Singer to William J. Gartland
34 of 66
Letter from Maxine Singer to Willard Gaylin
35 of 66
Letter from Maxine Singer to Wallace P. Rowe
36 of 66
Letter from Maxine Singer to U.S. Representative Richard Ottinger
37 of 66
Letter from Maxine Singer to Robert L. Sinsheimer
38 of 66
Letter from Maxine Singer to Milton P. Gordon
39 of 66
Letter from Maxine Singer to Lorill Brown-Rezanka
40 of 66
Letter from Maxine Singer to London Ganning
41 of 66
Letter from Maxine Singer to Donald S. Fredrickson
42 of 66
Letter from Maxine Singer to Charles Warren
43 of 66
Letter from Maxine Singer to Carolyn E. Kemp
44 of 66
Letter from London Ganning to Maxine Singer
45 of 66
Letter from Joshua Lederberg to U.S. Senators Alan Cranston and Samuel Ichiye Hayakawa
46 of 66
Letter from David S. Hogness to DeWitt Stetten, Jr
47 of 66
Letter from David Baltimore to Fred C. Ikle
48 of 66
Letter from Charles Warren and Barry Keene to Maxine Singer
49 of 66
Letter from Carolyn E. Kemp to Maxine Singer
50 of 66
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
51 of 66
David Hogness speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
52 of 66
David Baltimore speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
53 of 66
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
54 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
55 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
56 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
57 of 66
Appendix H: Provisional Statement of the Conference Proceedings
58 of 66
Appendix F: Cloned Eukaryotic DNA
59 of 66
Appendix F: Cloned Eukaryotic DNA
60 of 66
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
61 of 66
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
62 of 66
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
63 of 66
Appendix C: Program of the International Conference on Recombinant DNA Molecules
64 of 66
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
65 of 66
A Statement
66 of 66
previous image
next image
Pause Slideshow
Start Slideshow